Rare diseases
Investigational molecules
Locations
Back to Poland339 clinical trials in Rzeszow, Poland across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandA study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin
PolandA study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups
PolandA Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is
PolandA study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes not well controlled by diet and exercise
PolandA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
PolandStudy of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years
PolandStudy of Tozorakimab to reduce exacerbations in former smokers with chronic obstructive pulmonary disease (COPD)
PolandSafety and effectiveness study of inhaled ARCT-032 (mRNA therapy) in adults with Cystic Fibrosis
PolandStudy of ruxolitinib cream applied to the skin for people with hidradenitis suppurativa
PolandStudy on the Effects of EVO756 in Adults with Moderate to Severe Chronic Spontaneous Urticaria
PolandStudy on the Effectiveness and Safety of SAR441566 for Adults with Moderate-to-Severe Ulcerative Colitis
PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focusing on innovative treatments for inflammatory bowel diseases and autoimmune conditions, including studies on new therapies for ulcerative colitis and Crohn's disease.
Multiple trials evaluating novel compounds and biological therapies for inflammatory conditions.
Studies investigating treatments for heart failure prevention and metabolic disorders, with emphasis on innovative therapeutic approaches for obesity and cardiovascular health.
Focus on combination therapies and novel compounds for cardiometabolic conditions.
Clinical investigations targeting multiple sclerosis and chronic inflammatory conditions affecting the nervous system.
Evaluation of new therapeutic agents for managing neurological and immune-mediated conditions.
Research on various specialized conditions including geographic atrophy and reproductive health treatments.
Diverse studies focusing on improving patient outcomes across multiple therapeutic areas.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
